Evolent Health (NYSE: EVH) reported Q2 EPS of ($0.12), $0.04 better than the analyst estimate of ($0.16). Revenue for the quarter came in at $56.5 million versus the consensus estimate of $52.1 million.

GUIDANCE:

Evolent Health sees FY2016 revenue of $224-226 million, versus the consensus of $221.3 million.

For earnings history and earnings-related data on Evolent Health (EVH) click here.